You can also read this as a web version. To ensure your SelectScience emails arrive in your inbox, please add newswires@selectscience.com to your address book or safe list.

What's new in cancer research

November 2025 | By Matilde Marques, Editor

Resource

Mapping human tissues with 6-base sequencing

biomodal showcases how 6-base sequencing, using duet evoC and their new analysis software modality XPLR, can simultaneously profile 5mC and 5hmC across tissues, revealing distinct epigenetic signatures and regulatory pathways that define tissue identity and advance gene regulation research.

Revolutionary advancements in dna origami nanotechnology are transforming breast cancer detection

Article

DNA origami nanotechnology for breast cancer detection

Researchers at the University of Fribourg are pioneering a DNA origami nanotechnology that detects specific microRNAs in blood, offering a fast, accurate, and affordable point-of-care approach to breast cancer screening and patient monitoring.

Article

How researchers share breakthrough cancer tools

Discover how CancerTools.org is empowering the distribution of researcher-created tools across the globe. In partnership with Cancer Research UK, the platform accelerates discovery and ensures innovations reach scientists worldwide.

Resource

The tumor microenvironment: A complex ecosystem

This new whitepaper explores how the tumor microenvironment drives cancer progression, immune evasion, and treatment resistance, offering actionable insights for researchers, drug developers, and oncologists. Discover how advanced proteomics can identify key biomarkers and guide the development of personalized therapies.

Resource

Gadobutrol-enhanced optical clearing for in vivo fluorescence imaging

Analytik Jena unveils new data showing how gadobutrol-based optical clearing significantly enhances in vivo fluorescence imaging using the UVP iBox Studio system. The study reveals up to a 60% increase in fluorescence signal, delivering enhanced sensitivity and powerful new advantages for cancer model research.

Article

Curated biospecimen data drives the next era of AI in digital pathology

In this article, Daryl Waggott of BioIVT explores how linking whole-slide images with rich clinical and molecular context is enabling smarter, biologically informed algorithms, moving beyond pattern recognition to true tissue intelligence and advancing cancer research.

Article

How data and AI are accelerating cancer clinical trials

Phesi founder, Dr. Gen Li, explains how patient-centric data science and AI are reshaping the landscape of cancer clinical trials. Using real-world data and predictive analytics, the Trial Accelerator™ platform improves trial design, enhances patient selection, and reduces participant burden.

Editorial picks

eBook

High-throughput single cell screening

Learn how cutting-edge, scalable platforms are transforming RNA sequencing, CRISPR screening, and DNA methylation studies at a fraction of the cost and complexity.

Poster

Generation and characterization of diverse modality ADCs

Discover ChemPartner's comprehensive development and screening services for clients developing multispecific or dual-payload ADCs.

eBook

How to Buy 3D Biology Solutions

Explore the potential of 3D cell culture with this free eBook, offering expert tips on selecting systems and workflows for organoids, spheroids, and disease models.